Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom

被引：0
作者：
Xie, J. [1 ]
Yong, A. S. M. [2 ]
Waweru, C. [1 ]
Sorof, T. -A. [3 ]
Goyal, R. K. [4 ]
Davis, K. L. [4 ]
Hillmen, P. [5 ]
机构：
[1] AstraZeneca LP, Gaithersburg, MD USA
[2] AstraZeneca, Luton, Beds, England
[3] Acerta Pharma, San Francisco, CA USA
[4] RTI Hlth Solut, Res Triangle Pk, NC USA
[5] St James Univ Hosp, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-EP
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [31] Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients
    McCulloch, Rory
    Lewis, David
    Crosbie, Nicola
    Eyre, Toby A.
    Bolam, Simon
    Arasaretnam, Anita
    Creasey, Thomas
    Goradia, Harshita
    McMillan, Annabel
    Dawi, Safia
    Harrison, Samuel
    Miles, Oliver
    Robinson, Andrew
    Dutton, David
    Wilson, Matthew R.
    McKay, Pam
    Follows, George
    Phillips, Neil
    Patmore, Russell
    Lambert, Jonathan
    Bishton, Mark
    Osborne, Wendy
    Johnston, Rosalynd
    Kirkwood, Amy A.
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (02) : 290 - 298
  • [32] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [33] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    McDaniel, Brandon T.
    Cornet, Victor
    Carroll, Jeanne
    Chrones, Lambros
    Chudzik, Joseph
    Cochran, Jeanette
    Guha, Shion
    Lawrence, Debra F.
    McCue, Maggie
    Sarkey, Sara
    Lorenz, Betty
    Fawver, Jay
    BMC PSYCHIATRY, 2023, 23 (01)
  • [34] Real-world outcomes following adverse events and dose reduction of first-line ibrutinib in Medicare beneficiaries with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shadman, Mazyar
    Srivastava, Bhavini P.
    Salkar, Monika
    Saifan, Chadi
    Agatep, Barnabie C.
    Jones, Barton
    Ryan, Olga
    Bacchus, Shaffee
    Stephens, Deborah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in he United States
    Mato, Anthony R.
    Thompson, Meghan
    Allan, John N.
    Brander, Danielle M.
    Pagel, John M.
    Ujjani, Chaitra S.
    Hill, Brian T.
    Lamanna, Nicole
    Lansigan, Frederick
    Jacobs, Ryan
    Shadman, Mazyar
    Skarbnik, Alan P.
    Pu, Jeffrey J.
    Barr, Paul M.
    Sehgal, Alison R.
    Cheson, Bruce D.
    Zent, Clive S.
    Tuncer, Hande H.
    Schuster, Stephen J.
    Pickens, Peter V.
    Shah, Nirav N.
    Goy, Andre
    Winter, Allison M.
    Garcia, Christine
    Kennard, Kaitlin
    Isaac, Krista
    Dorsey, Colleen
    Gashonia, Lisa M.
    Singavi, Arun K.
    Roeker, Lindsey E.
    Zelenetz, Andrew
    Williams, Annalynn
    Howlett, Christina
    Weissbrot, Hanna
    Ali, Naveed
    Khajavian, Sirin
    Sitlinger, Andrea
    Tranchito, Eve
    Rhodes, Joanna
    Felsenfeld, Joshua
    Bailey, Neil
    Patel, Bhavisha
    Burns, Timothy F.
    Yacur, Melissa
    Malhotra, Mansi
    Svoboda, Jakub
    Furman, Richard R.
    Nabhan, Chadi
    HAEMATOLOGICA, 2018, 103 (09) : 1511 - 1517
  • [36] Real-World Dosing Patterns and Time to Next Treatment for Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With or Without Ibrutinib Dose Reduction Following an Adverse Event
    Shadman, Mazyar
    Srivastava, Bhavini P.
    Patel, Sima
    Saifan, Chadi
    Salkar, Monika
    Emond, Bruno
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Stephens, Deborah M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S327 - S327
  • [37] TREATMENT PATTERNS AND ADVERSE EVENTS (AES) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/ SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) IN FRANCE, ITALY, AND THE UNITED KINGDOM (UK)
    Ysebaert, L.
    Bahar, N.
    Milloy, N.
    Kluth, C.
    Prieto, A.
    VALUE IN HEALTH, 2023, 26 (12) : S315 - S316
  • [38] Venetoclax: a chance for patients with chronic lymphocytic leukaemia previously treated with ibrutinib
    Mauro, Francesca R.
    Foa, Robin
    LANCET ONCOLOGY, 2018, 19 (01) : 7 - 8
  • [39] Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL)
    Krackeler, Margaret
    Chee, Bryant
    Orchanian, Arthur K.
    Law, Lisa Y.
    Lopez, Alfredo R.
    Buchanan, Susan
    Maglinte, Gregory A.
    Liu, Raymond
    Zhu, Zheng
    Sakoda, Lori C.
    Tavakoli, Jahan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] A Real-World Evidence Study of the Temporal Evolution in Treatment Patterns and Outcomes for Chronic Lymphocytic Leukemia
    Cheung, Winson Y.
    Boyne, Devon J.
    Jarada, Tamer N.
    Carbonell, Chantelle
    Owen, Carolyn
    BLOOD, 2023, 142
12345